(S)-1-Boc-3-Hydroxypiperidine CAS 143900-44-1 Ibrutinib Nadiif Dhexdhexaad ah>99.0% (GC)
Dhexdhexaadiyeyaasha la xidhiidha Ibrutinib:
(S)-1-Boc-3-Hydroxypiperidine CAS 143900-44-1
4-Phenoxyphenylboronic Acid CAS 51067-38-0
Ibrutinib Dhexdhexaad N-2 CAS 330786-24-8
Ibrutinib Dhexdhexaad N-3 CAS 330792-70-6
Ibrutinib CAS 936563-96-1
Magaca Kiimikada | (S)-1-Boc-3-Hydroxypiperidine |
La mid ah | (S)-1-(tert-Butoxycarbonyl)-3-Hydroxypiperidine;(S)-1-Boc-3-Piperidinol |
Lambarka CAS | 143900-44-1 |
Lambarka CAT | RF-CC299 |
Heerka Saamiyada | Kaydka dhexdiisa, Awoodda Wax-soo-saarka 20 Tan/Bishii |
Qaanuunka molecular | C10H19NO3 |
Miisaanka Molecular | 201.27 |
Meesha dhalaalaysa | 52.0 ~ 56.0 ℃ |
Solubility | Ku milma Methanol |
Wareeg gaar ah [a]20/D | +9.0°~+11.0° (C=1 gudaha Chloroform) |
Summada | Kiimikada Ruifu |
Shayga | Tilmaamaha |
Muuqashada | Budada cad ama kiristaalo |
Daahirnimada Chiral | >99.5% (GC) |
Nadiifnimada Kiimikada | >99.5% (GC) |
Biyaha (KF) | ≤0.50% |
Methanol (GC) | ≤50pm |
Ethanol (GC) | ≤50pm |
DCM (GC) | ≤500pm |
3-Hydroxypiperidine | ≤0.10% |
3-Hydroxypyridine | ≤0.20% |
1-Boc-3-Piperidone | ≤0.10% |
1-Boc-4-Hydroxypiperidine | ≤0.10% |
1.96 RRT | ≤0.20% |
Najaasad kasta oo aan la cayimin | ≤0.10% |
Heerka Imtixaanka | Heerka Ganacsiga |
Isticmaalka | Dhexdhexaadiyeyaasha Dawooyinka;Isku dhafka Chiral |
Xidhmada: Dhalo, bacda bireed ee aluminium, 25kg/Drum kartoonada, ama sida waafaqsan shuruudaha macmiilka.
Xaaladda Kaydinta:Ku kaydi weelasha xiran meel qabow oo qallalan;Ka ilaali iftiinka iyo qoyaanka.
(S) -1-Boc-3-Hydroxypiperidine (CAS: 143900-44-1) waa dhexdhexaad muhiim ah oo chiral ah oo loogu talagalay isku dhafka Ibrutinib (CAS: 936563-96-1).Ibrutinib waa nooc ka mid ah Bruton tyrosine kinase (BTK) inhibitor, waxaa loo isticmaali karaa daaweynta lymphocytic leukemia raaga (CLL) iyo mantle cell lymphoma (MCL).MCL iyo CLL waxay ka tirsan yihiin B-cell non-Hodgkin's lymfoma, taas oo ay adag tahay in la daweeyo oo ay fududahay in ay soo noqnoqdaan.Dawaynta kiimikaad ee caadiga ah ma laha bartilmaameedka, badanaa waxay dhacdaa 3 ama 4 falcelin xun.Ibrutinib iyo B lymphocytes waxay bartilmaameedsan karaan BTK oo lagama maarmaan u ah samaynta, kala soocida, iyo gudbinta macluumaadka, waxay joojiyaan dhaqdhaqaaqa BTK si aan leexleexad lahayn, waxayna u diidaan faafinta unugyada burooyinka iyo badbaadada si wax ku ool ah.Ibrutinib si dhakhso ah ayaa loo nuugi karaa ka dib maamulka afka, inta lagu jiro 1 ~ 2h waxay gaaraan heerka ugu sarreeya ee dhiigga, falcelinta xun waxay ka tirsan tahay hal ama laba, sidaas darteed, Ibrutinib wuxuu noqon doonaa doorasho cusub oo lagu daweeyo CLL iyo MCL.